11820-1-AP

antibody from Proteintech Group

Targeting: SDC4 amphiglycan, ryudocan, SYND4

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

11820-1-AP

Provider

Proteintech Group

Product name

SDC4 antibody

Antibody type

Polyclonal

Description

KD/KO validated SDC4 antibody (Cat. #11820-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Unraveling cellular dynamic changes in tumor evolution induced by long-term low dose-rate radiation.

Li W, Pei W, Wang Y, Nie J, Hu G, Zhang Y, Cao Z, Chen Z, Miao K, Chen Y, Shi L, Dai Y, Liu N, Pei H, Ye C, Ali YF, Hu W, Yan W, Zhou G
British journal of cancer 2025 Nov;133(9):1278-1296

---

Insight into perfluorooctanoic acid-induced impairment of mouse embryo implantation via single-cell RNA-seq.

Sheng X, Yang Y, Tian J, Zhang Z, Ding L, Zhao J
Journal of hazardous materials 2025 May 5;488:137375

---

Microbial production of short-chain fatty acids attenuates long-term neurologic impairment after traumatic brain injury.

Xiong Z, Dodson BP, Rogers MB, Sneiderman CT, Janesko-Feldman K, Vagni V, Manole M, Li X, Rajasundaram D, Clark RSB, Raphael I, Morowitz MJ, Mariño E, Kochanek PM, Jha RM, Kohanbash G, Simon DW
Journal of neuroinflammation 2025 Dec 9;22(1):285

---

Neutrophil extracellular traps induced by neoadjuvant chemotherapy of breast cancer promotes vascular endothelial damage.

Kong L, Hu S, Zhao Y, Huang Y, Xiang X, Yu Y, Mao X, Xie K, Zhu X, Xu P
Breast cancer research : BCR 2025 Apr 23;27(1):61

---

Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.

Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Hata T, Nagayama S, Kagawa K, Goto Y, Utou M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Takahashi K, Niida A, Hirose H, Hayashi S, Koseki J, Fukuchi S, Murakami K, Yoshizumi T, Kadomatsu K, Tobo T, Oda Y, Uemura M, Eguchi H, Doki Y, Mori M, Oshima M, Shibata T, Suzuki Y, Shimamura T, Mimori K
EBioMedicine 2024 May;103:105102

---

Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.

Cui S, Chen X, Li J, Wang W, Meng D, Zhu S, Shen S
Cell communication and signaling : CCS 2024 Mar 25;22(1):191

---

Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma.

Dantzer C, Vaché J, Brunel A, Mahouche I, Raymond AA, Dupuy JW, Petrel M, Bioulac-Sage P, Perrais D, Dugot-Senant N, Verdier M, Bessette B, Billottet C, Moreau V
eLife 2024 Jul 15;13

---

Single-cell RNA sequencing reveals the intercellular crosstalk and the regulatory landscape of stromal cells during the whole life of the mouse ovary.

Jiang W, Sun W, Peng Y, Xu H, Fan H, Jin X, Xiao Y, Wang Y, Yang P, Shu W, Li J
Life medicine 2024 Dec;3(6):lnae041

---

Bioinformatics analysis identifies heparan sulfate proteoglycans acting as different progress subtypes of biliary atresia.

Ding Z, Song W, Zhu W, Xie H, Zhu Z, Tang W
Frontiers in pediatrics 2023;11:1065521

---

Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion.

Yang X, Li Y, Liu G, Zha W, Liu Y
Oncology letters 2022 May;23(5):145

---

Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy.

Liu TT, Yang H, Zhuo FF, Yang Z, Zhao MM, Guo Q, Liu Y, Liu D, Zeng KW, Tu PF
EBioMedicine 2022 Dec;86:104353

---

Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma.

Yang H, Liu Y, Zhao MM, Guo Q, Zheng XK, Liu D, Zeng KW, Tu PF
Cell death & disease 2021 May 14;12(5):492

---

Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics.

Yin L, Qi Y, Xu Y, Xu L, Han X, Tao X, Song S, Peng J
Frontiers in pharmacology 2017;8:665